Journey Medical Corporation/$DERM
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Ticker
$DERM
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Employees
41
ISIN
US48115J1097
Website
DERM Metrics
BasicAdvanced
$164M
-
-$0.39
0.88
-
Price and volume
Market cap
$164M
Beta
0.88
52-week high
$8.25
52-week low
$4.97
Average daily volume
159K
Financial strength
Current ratio
1.342
Quick ratio
0.972
Long term debt to equity
107.697
Total debt to equity
116.833
Interest coverage (TTM)
-2.27%
Profitability
EBITDA (TTM)
-3.445
Gross margin (TTM)
65.03%
Net profit margin (TTM)
-14.76%
Operating margin (TTM)
-12.29%
Effective tax rate (TTM)
-0.74%
Revenue per employee (TTM)
$1,370,000
Management effectiveness
Return on assets (TTM)
-5.70%
Return on equity (TTM)
-48.14%
Valuation
Price to revenue (TTM)
2.647
Price to book
7.55
Price to tangible book (TTM)
-17.57
Price to free cash flow (TTM)
-6.785
Free cash flow yield (TTM)
-14.74%
Free cash flow per share (TTM)
-103.76%
Growth
Revenue change (TTM)
-29.69%
Earnings per share change (TTM)
76.75%
3-year revenue growth (CAGR)
-9.43%
3-year earnings per share growth (CAGR)
-52.79%
DERM News
AllArticlesVideos
Journey Medical to Join Russell 2000® and Russell 3000® Indexes
GlobeNewsWire·1 week ago
Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference
GlobeNewsWire·2 weeks ago
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Journey Medical Corporation stock?
Journey Medical Corporation (DERM) has a market cap of $164M as of July 04, 2025.
What is the P/E ratio for Journey Medical Corporation stock?
The price to earnings (P/E) ratio for Journey Medical Corporation (DERM) stock is 0 as of July 04, 2025.
Does Journey Medical Corporation stock pay dividends?
No, Journey Medical Corporation (DERM) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next Journey Medical Corporation dividend payment date?
Journey Medical Corporation (DERM) stock does not pay dividends to its shareholders.
What is the beta indicator for Journey Medical Corporation?
Journey Medical Corporation (DERM) has a beta rating of 0.88. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.